Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The New Era of Multiple Sclerosis Therapeutics.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
[Special cases of multiple sclerosis].
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
[Vitamin D and multiple sclerosis : The role for risk of disease and treatment.]
A qualitative study of the childbearing experience of women living with multiple sclerosis.
MicroRNA dysregulation in multiple sclerosis.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Pages
« first
‹ previous
…
286
287
288
289
290
291
292
293
294
…
next ›
last »